Demographic Characteristics of TAK-003 Dengue Vaccine Recipients in Vietnam

计划入组 800,000 人 · 首次发布于 2026 年 3 月 30 日

Revaccination With Subunit Influenza A/Vietnam/1203/2004 (H5N1) Vaccine

计划入组 37 人 · 首次发布于 2005 年 10 月 18 日

Trial of Pneumococcal Vaccine Schedules in Ho Chi Minh City, Vietnam

计划入组 1,400 人 · 首次发布于 2013 年 10 月 1 日

COVIVAC vaccine(Institute Of Vaccines And Medical Biologicals, Vietnam)

Influenza A virus A/Vietnam/1194/2004 (H5N1) antigen (formaldehyde inactivated)(FOCLIVIA)

BCD-115

Jsc Grindeks

JSC "VALENTA PHARM"

Russia

Nanogen Pharmaceutical Biotechnology JSC

Vietnam

Sanofi and VNVC Launch $77 Million Vaccine Manufacturing Facility in Vietnam

Vietnam Signs Agreement to Access Russia's Potential mRNA Cancer Vaccine

Vietnam Announces Plans to Join International mRNA Cancer Vaccine Clinical Trials Starting 2026